Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjogren's syndrome

被引:16
作者
Skoumal, M
Haberhauer, G
Feyertag, J
Kittl, EM
Bauer, K
Dunky, A
机构
[1] SVA gewerblichen Wirtschaft, Rheumasonderkrankenanstalt, A-2500 Baden, Austria
[2] Donauuniv Krems, Inst Rheumatol, Baden, Austria
[3] Wilhelminen Hosp Vienna, Dept Internal Med 5, Vienna, Austria
[4] Danube Hosp, Cent Lab, Vienna, Austria
关键词
D O I
10.1186/ar1161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:73 / 74
页数:2
相关论文
共 7 条
[1]   Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept [J].
Crnkic, M ;
Månsson, B ;
Larsson, L ;
Geborek, P ;
Heinegård, D ;
Saxne, T .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (04) :R181-R185
[2]  
Di Cesare PE, 1999, J ORTHOPAED RES, V17, P437
[3]   Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts [J].
Dodge, GR ;
Hawkins, D ;
Boesler, E ;
Sakai, L ;
Jimenez, SA .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 (06) :435-440
[4]  
FORSLIND K, 1992, BRIT J RHEUMATOL, V31, P593
[5]  
Hummel KM, 1998, BRIT J RHEUMATOL, V37, P721
[6]  
OLDBERG A, 1992, J BIOL CHEM, V267, P22346
[7]   Serum levels of cartilage oligomeric matrix protein - A predicting factor and a valuable parameter for disease management in rheumatoid arthritis [J].
Skoumal, M ;
Kolarz, G ;
Klingler, A .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2003, 32 (03) :156-161